Clinical Trials on Hyperplasia in Hong Kong
Total 32 results
-
Chinese University of Hong KongCompletedBenign Prostate HyperplasiaHong Kong
-
Chinese University of Hong KongTerminated
-
Chinese University of Hong KongKoelisRecruitingProstate HyperplasiaHong Kong
-
Chinese University of Hong KongSchool of Pharmacy, CUHKCompletedBenign Prostate HyperplasiaHong Kong
-
Chinese University of Hong KongTerminatedBenign Prostatic HyperplasiaHong Kong
-
The University of Hong KongUnknownProstatic Hyperplasia | Prostate CancerHong Kong
-
Chinese University of Hong KongRecruitingBenign Prostatic HyperplasiaHong Kong
-
Hospital Authority, Hong KongUnknownProstatic Hyperplasia | Adrenergic Alpha-AntagonistsChina
-
Chinese University of Hong KongRecruitingProstate HyperplasiaHong Kong
-
Chinese University of Hong KongActive, not recruitingBenign Prostatic Hyperplasia (BPH)Hong Kong
-
Hospital Authority, Hong KongTerminatedProstatic Hyperplasia | Urinary RetentionChina
-
Hospital Authority, Hong KongCompletedProstatic Hyperplasia | ImpotenceChina
-
Hospital Authority, Hong KongTerminatedProstatic Hyperplasia | Acute Disease | Urinary RetentionChina
-
The University of Hong KongUnknown
-
PROCEPT BioRoboticsRecruitingBenign Prostatic Hyperplasia | Localized Prostate CancerLebanon, Hong Kong, United States
-
The University of Hong KongCompletedCleft Lip and Palate | Maxillary HypoplasiaHong Kong
-
University of California, IrvinePomegranate Health; Jarrow PharmaceuticalsUnknownBenign Prostatic HyperplasiaUnited States
-
Merit Medical Systems, Inc.TerminatedBenign Prostatic HyperplasiaUnited States
-
Medi-Tate Ltd.CompletedBenign Prostate HyperplasiaUnited States, Canada
-
GlaxoSmithKlineCompletedProstatic HyperplasiaUnited States
-
Sophiris Bio CorpCompletedBenign Prostatic HyperplasiaUnited States
-
Merit Medical Systems, Inc.CompletedLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaUnited States, United Kingdom, Italy, France
-
PROCEPT BioRoboticsCompletedBenign Prostatic Hyperplasia (BPH)United States, Canada
-
Nymox CorporationCompletedPhase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)Benign Prostatic Hyperplasia (BPH) | Enlarged ProstateUnited States
-
Threshold PharmaceuticalsTerminatedBenign Prostatic HyperplasiaUnited States
-
Nymox CorporationCompletedBenign Prostatic HyperplasiaUnited States
-
Watson PharmaceuticalsCompletedBenign Prostatic Hyperplasia (BPH)United States
-
Watson PharmaceuticalsCompletedBenign Prostatic HyperplasiaUnited States
-
Eli Lilly and CompanyCompletedBenign Prostatic Hyperplasia | Enlarged ProstateUnited States, Italy, France, Belgium, Mexico, Argentina, Greece, Germany, Canada, Russian Federation, Poland, Turkey, Brazil
-
Sophiris Bio CorpCompletedBenign Prostatic HyperplasiaUnited States, Australia, Canada, Russian Federation, Ukraine, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingStage I Kidney Wilms Tumor | Stage II Kidney Wilms Tumor | Stage III Kidney Wilms Tumor | Stage IV Kidney Wilms Tumor | Adult Kidney Wilms Tumor | Beckwith-Wiedemann Syndrome | Childhood Kidney Wilms Tumor | Diffuse Hyperplastic Perilobar Nephroblastomatosis | Rhabdoid Tumor of the Kidney | Stage V Kidney...United States, Canada, Australia, New Zealand, Puerto Rico, Israel
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingRenal Cell Carcinoma | Wilms Tumor | Clear Cell Sarcoma of the Kidney | Papillary Renal Cell Carcinoma | Kidney Medullary Carcinoma | Diffuse Hyperplastic Perilobar Nephroblastomatosis | Rhabdoid Tumor of the Kidney | Congenital Mesoblastic Nephroma | Renal Cell Carcinoma Associated With Xp11.2 Translocations... and other conditionsUnited States, Canada, Puerto Rico, Australia, New Zealand, Israel, Switzerland